Denali Therapeutics Inc. (DNLI) declined -5.54% or -0.74 to $12.63. It is nearly 362035 shares traded, which is 80.55% compare to the average total volume 449441. The market cap of DNLI is $1.19 billion. The year to date change is -22.65%. The 52 week price range is from $12.63 to $25.79. Price of DNLI have changed -0.67% during last week. It have changed -21.72% over last month, -28.50% over last 3 months, -39.77% over last 6 months and -37.67% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 17.23. It is 36.42% above current price. The 200-day Moving Averages for DNLI is 18.95. It is 50.04% above current price. The 52-week High is 25.79. It is 104.20% from the current price. The 52-week Low is 12.63. The stock hits 52-week low today.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of DNLI is 15.47 on 2018-07-13. Short % to float is 7.14%. There are some statistics of DNLI. It is has market cap $1.19 billion. The share outstanding is 94.44 million. The average volume is 449441. The percent of top 15 Institution holding is 87.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -16.80%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -14.75%.